Form D/A — Proxima Bio, Inc.
0002104665-26-000003 · filed Jun 10, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $91,454,999
- Reported amount sold
- $91,454,999
- Minimum investment
- $1
- Investors
- 11
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Proxima Bio, Inc.
- CIK
- 2104665
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 116 E 16TH STREET
NEW YORK, NY 10003 - Phone
- 212-516-8509
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Zachary Carpenter · Executive OfficerNew York, NY Find on LinkedIn ↗
-
John McFarland · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Alex Gasner · DirectorNew York, NY Find on LinkedIn ↗
-
Jason Pontin · DirectorNew York, NY Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗